Mesa Laboratories (MLAB) Gains from Sales and Divestitures (2018 - 2025)
Mesa Laboratories (MLAB) has disclosed Gains from Sales and Divestitures for 8 consecutive years, with $65.0 as the latest value for Q4 2025.
- Quarterly Gains from Sales and Divestitures rose 441.67% to $65.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.0 through Dec 2025, up 441.67% year-over-year, with the annual reading at $12000.0 for FY2025, 57.14% down from the prior year.
- Gains from Sales and Divestitures hit $65.0 in Q4 2025 for Mesa Laboratories, up from $62.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $28000.0 in Q3 2021 to a low of $4.0 in Q2 2025.
- Historically, Gains from Sales and Divestitures has averaged $8367.8 across 5 years, with a median of $65.0 in 2025.
- Biggest five-year swings in Gains from Sales and Divestitures: surged 1200.0% in 2022 and later plummeted 99.85% in 2023.
- Year by year, Gains from Sales and Divestitures stood at $28.0 in 2021, then plummeted by 64.29% to $10.0 in 2022, then surged by 170.0% to $27.0 in 2023, then tumbled by 55.56% to $12.0 in 2024, then skyrocketed by 441.67% to $65.0 in 2025.
- Business Quant data shows Gains from Sales and Divestitures for MLAB at $65.0 in Q4 2025, $62.0 in Q3 2025, and $4.0 in Q2 2025.